Evidence map›Paper›PMID 22483619›Full record

ArticleMolecular cell2012

mRNA decapping factors and the exonuclease Xrn2 function in widespread premature termination of RNA polymerase II transcription.

Kris Brannan, Hyunmin Kim, Benjamin Erickson, Kira Glover-Cutter, Soojin Kim, Nova Fong, Lauren Kiemele, Kirk Hansen, Richard Davis, Jens Lykke-Andersen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 199 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kris BrannanDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Hyunmin Kim
Benjamin Erickson
Kira Glover-Cutter
Soojin Kim
Nova Fong
Lauren Kiemele
Kirk Hansen
Richard Davis
Jens Lykke-Andersen
David L Bentley
University of California, San Diego · USUniversity of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
IN VIVO ANALYSIS OF SL ADDITION IN ASCARIS EMBRYOSR01AI049558 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DAVIS, RICHARD E. · 2000 to 2015
$4.8M
Elongation and termination of trascripts by RNA pol IIR01GM063873 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BENTLEY, DAVID L · 2003 to 2016
$3.5M
Predoctoral Training Program in Molecular BiologyT32GM008730 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PREKERIS, RYTIS, SCLAFANI, ROBERT A · 1999 to 2019
$3.3M
LTQ FT-ICR Hybrid Mass Spectrometer PurchaseS10RR023015 · NCRR · UNIVERSITY OF COLORADO DENVER · PI HANSEN, KIRK C · 2007 to 2007
$1.1M
Uncapped Potential:Capping enzymes/transcription factorsF31GM072099 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI GLOVER, KIRA M · 2004 to 2007
$114k
Molecular analysis of transcription termination by human RNA polymerase IIF31GM095249 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BRANNAN, KRISTOPHER · 2011 to 2013
$85k
NCI NIH HHS P30 CA046934NCI NIH HHS P30 CA046934-17NCRR NIH HHS S10 RR023015NCRR NIH HHS S10RR023015NIAID NIH HHS AI49558NIAID NIH HHS R01 AI049558NIGMS NIH HHS 3R01GM063873-06S1NIGMS NIH HHS F31 GM072099NIGMS NIH HHS F31 GM095249NIGMS NIH HHS F31GM095249NIGMS NIH HHS F31GM72099NIGMS NIH HHS GM063873NIGMS NIH HHS R01 GM063873NIGMS NIH HHS T32 GM008730NIGMS NIH HHS T32-GM08730
6 · The paper itself

Abstract

We report a function of human mRNA decapping factors in control of transcription by RNA polymerase II. Decapping proteins Edc3, Dcp1a, and Dcp2 and the termination factor TTF2 coimmunoprecipitate with Xrn2, the nuclear 5'-3' exonuclease "torpedo" that facilitates transcription termination at the 3' ends of genes. Dcp1a, Xrn2, and TTF2 localize near transcription start sites (TSSs) by ChIP-seq. At genes with 5' peaks of paused pol II, knockdown of decapping or termination factors Xrn2 and TTF2 shifted polymerase away from the TSS toward upstream and downstream distal positions. This redistribution of pol II is similar in magnitude to that caused by depletion of the elongation factor Spt5. We propose that coupled decapping of nascent transcripts and premature termination by the "torpedo" mechanism is a widespread mechanism that limits bidirectional pol II elongation. Regulated cotranscriptional decapping near promoter-proximal pause sites followed by premature termination could control productive pol II elongation.

Indexed as

RNA StabilityAdenosine TriphosphatasesDNA-Binding ProteinsExoribonucleasesHEK293 CellsHeLa CellsHumansModels, GeneticProtein Interaction MappingRNA, MessengerRNA Polymerase IITranscription FactorsTranscription, GeneticAdenosine TriphosphatasesDNA-Binding ProteinsExoribonucleasesRNA, MessengerRNA Polymerase IITranscription FactorsTTF2 protein, humanXRN2 protein, human

Identifiers

PMID22483619
PMCPMC3806456
OpenAlexW2067058481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.